SCHEMBL5570285

SCHEMBL5570285

CCCCCCN1C(=O)CC(=O)N(CCCCCC)C1=S

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.50
FAAH O00519 4/20 0.50
PTGS1 P23219 3/20 0.50
PTGS2 P35354 3/20 0.50
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.43
THRB P10828 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP19A1 P11511 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
CNR2 P34972 3/20 0.39
CES1 P23141 2/20 0.39
CDC25A P30304 1/20 0.39
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8652814 0.98 MGLL (0.47) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL12101786 0.96 MGLL (0.46) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL145408 0.92 KDM4E (0.46) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL3142849 0.88 KDM4E (0.42) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL3142469 0.88 MGLL (0.40) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL4639742 0.86 MGLL (0.55) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL8121430 0.84 MAPT (0.54) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL5450752 0.84 MAPT (0.54) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL8115352 0.84 MAPT (0.54) MGLLFAAHPTGS1PTGS2GAA
SCHEMBL4578069 0.84 MAPT (0.54) MGLLFAAHPTGS1PTGS2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117858875-A Hydroxy-and (halo) alkoxy-substituted tetrahydrofurans as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-09 CN disclosed
CN-117813302-A Substituted tetrahydrofuran-2-carboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-04-02 CN disclosed
CN-117794918-A Substituted tetrahydrofuran analogues as sodium channel modulators 沃泰克斯药物股份有限公司 2024-03-29 CN disclosed
CN-117794920-A N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamides as sodium channel modulators 沃泰克斯药物股份有限公司 2024-03-29 CN disclosed
CN-117794919-A N- (hydroxyalkyl (hetero) aryl) tetrahydrofurancarboxamide analogues as sodium channel modulators 沃泰克斯药物股份有限公司 2024-03-29 CN disclosed
US-7173130-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-06 US disclosed
US-7118899-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-10 US disclosed
US-7115401-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-03 US disclosed
EP-0834074-B2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 2005-11-16 EP disclosed
US-20040002123-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2004-01-01 US disclosed
US-6596522-B2 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-22 US disclosed
US-20020164577-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-11-07 US disclosed
US-20020137201-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-09-26 US disclosed
US-6342379-B1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-01-29 US disclosed
US-6107066-A Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-22 US disclosed
EP-0834074-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-04-08 EP disclosed
WO-1996041166-A2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002123-A1 Detection of transmembrane potentials by optical methods TRPV1, TRPM2, MCU MGLL 1219/4885FAAH 1435/4885PTGS1 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.